Last $2.28 USD
Change Today 0.00 / 0.00%
Volume 1.1M
DNDN On Other Exchanges
Symbol
Exchange
DNDN is not on other exchanges.
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John H. Johnson

Chief Executive Officer and President, Dendreon Corp.
AgeTotal Calculated CompensationThis person is connected to 43 board members in 3 different organizations across 10 different industries.

See Board Relationships
56$5,578,355
As of Fiscal Year 2013

Background*

Mr. John H. Johnson is a Founder of The Atlantic Foundation. Mr. Johnson has been the Chief Executive Officer and President of Dendreon Corp. since February 2012. Mr. Johnson served as the Chief Executive Officer of Savient Pharmaceuticals, Inc. from January 31, 2011 to February 1, 2012 and served as its President until February 1, 2012. He served as the President and Head of Lilly Oncology (Oncology Business Unit) and Senior Vice President of Eli Lilly and Company from ...

Read Full Background

Corporate Headquarters*

1301 2nd Avenue
Seattle, Washington 98101

United States

Phone: 206-256-4545
Fax: 206-256-0571

Board Members Memberships*

Former Director
Former Chief Executive Officer, President and Director
Former Chairman of the Board
Former Director
2007-2008
Former President of Global Oncology Business Unit - Eli Lilly and Company
2009-Present
Director and Member of Nominating & Governance Committee
2010-N/A
Chairman, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2011-2014
Chief Executive Officer and President
2013-Present
Independent Director
2014-Present
Director and Chairman of Compensation Committee

Education*

BS
East Stroudsburg University

Other Affiliations*

Annual Compensation*

Salary$800,000
Total Annual Compensation$800,000

Stock Options*

Restricted Stock Awards$4,314,644
All Other Compensation$7,711
Exercisable Options354,220
Unexercisable Options166,666
Total Number of Options688,494

Total Compensation*

Total Annual Cash Compensation$1,263,711
Total Short Term Compensation$800,000
Other Long Term Compensation$4,322,355
Total Calculated Compensation$5,578,355
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DNDN:US $2.28 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Spectrum Pharmaceuticals, Inc.
$1.8M
Aijaz Tobaccowalla Managing Director, Additional Non-Executive Director, Member of Share Transfer Committee, Member of Audit Committee and Member of Shareholders' / Investors' Grievance Committee
Wyeth Limited
--
Aijaz Tobaccowalla Managing Director, Additional Director and Member of Board Administrative Committee
Pfizer Limited
17.6M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DENDREON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.